Entity Common Stock, Shares Outstanding of Esperion Therapeutics, Inc. from 01 Aug 2013 to 01 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Esperion Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2013 to 01 Mar 2026.
  • Esperion Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 01 Mar 2026 was 256,810,482, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Esperion Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 256,810,482 +58,611,020 +30% 01 Mar 2026 10-K 10 Mar 2026 2025 FY
Q3 2025 239,063,437 +42,028,266 +21% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 201,622,825 +5,398,130 +2.8% 08 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 198,199,462 +8,739,169 +4.6% 01 May 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 197,035,171 +83,317,386 +73% 01 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 196,224,695 +89,230,426 +83% 01 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 189,460,293 +94,747,636 +100% 01 May 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 113,717,785 +40,034,213 +54% 01 Nov 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 106,994,269 +40,442,720 +61% 28 Jul 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 94,712,657 +31,706,038 +50% 01 May 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 76,572,830 +13,751,227 +22% 01 Feb 2023 10-K 21 Feb 2023 2022 FY
Q3 2022 73,683,572 +44,606,215 +153% 31 Oct 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 66,551,549 +38,274,056 +135% 01 Aug 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 63,006,619 +34,814,485 +123% 01 May 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 62,821,603 +34,878,991 +125% 01 Feb 2022 10-K 22 Feb 2022 2021 FY
Q3 2021 29,077,357 +1,200,731 +4.3% 01 Nov 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 28,277,493 +452,065 +1.6% 01 Aug 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 28,192,134 +574,703 +2.1% 01 May 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 27,942,612 +430,171 +1.6% 01 Feb 2021 10-K 23 Feb 2021 2020 FY
Q3 2020 27,876,626 +549,217 +2% 01 Nov 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 27,825,428 +654,748 +2.4% 01 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 27,617,431 +699,975 +2.6% 01 May 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 27,512,441 +687,582 +2.6% 01 Feb 2020 10-K 27 Feb 2020 2019 FY
Q3 2019 27,327,409 +516,407 +1.9% 01 Nov 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 27,170,680 +367,005 +1.4% 01 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 26,917,456 +131,859 +0.49% 01 May 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 26,824,859 +325,590 +1.2% 01 Feb 2019 10-K 28 Feb 2019 2018 FY
Q3 2018 26,811,002 +613,253 +2.3% 31 Oct 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 26,803,675 +4,210,513 +19% 01 Aug 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 26,785,597 +4,195,559 +19% 01 May 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 26,499,269 +3,943,856 +17% 01 Feb 2018 10-K 20 Feb 2018 2017 FY
Q3 2017 26,197,749 +3,643,898 +16% 01 Nov 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 22,593,162 +42,748 +0.19% 01 Aug 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 22,590,038 +49,010 +0.22% 01 May 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 22,555,413 +14,947 +0.07% 01 Feb 2017 10-K 22 Feb 2017 2016 FY
Q3 2016 22,553,851 +34,944 +0.16% 01 Nov 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 22,550,414 +61,678 +0.27% 01 Aug 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 22,541,028 +2,115,168 +10% 01 May 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 22,540,466 01 Feb 2016 10-K 25 Feb 2016 2015 FY
Q3 2015 22,518,907 +2,169,154 +11% 01 Nov 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 22,488,736 +7,043,733 +46% 01 Aug 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 20,425,860 +5,031,634 +33% 01 Mar 2015 10-K 10 Mar 2015 2014 FY
Q3 2014 20,349,753 +4,992,340 +33% 01 Nov 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 15,445,003 +87,590 +0.57% 01 Aug 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 15,394,226 01 Mar 2014 10-K 13 Mar 2014 2013 FY
Q3 2013 15,357,413 01 Nov 2013 10-Q 06 Nov 2013 2013 Q3
Q2 2013 15,357,413 01 Aug 2013 10-Q 12 Aug 2013 2013 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.